21 CFR 862.3555

§ 862.3555 Lidocaine test system.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 862.3555, § 862.3555 Lidocaine test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89269
Permanent ID: ys:prov:89269@1
SHA-256: d15dc1ec2f7670a664c843e20c17456370851eb8a038b9593aa379ef7228f0b9

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. A lidocaine test system is a device intended to measure lidocaine, an antiarrythmic and anticonvulsant drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of lidocaine overdose or in monitoring levels of lidocaine to ensure appropriate therapy. (b) Classification. Class II.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.